Free shipping on all orders over $ 500

 About 1 result found for searched term "1002101-19-0" (0.123 seconds)

Cat.No.  Name Target
M27599 Fezagepras GPR/FFAR
Setogepram; PBI-4050
Fezagepras (Setogepram) acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84. Fezagepras decreases renal, liver and pancreatic fibrosis. Fezagepras exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.